Harvard University Honors mClinica’s Farouk Meralli for Work Transforming Public Health in Asia

Endeavor Entrepreneur Farouk Meralli, founder and CEO of mClinica, was awarded the Public Health Innovator award by Harvard’s T.H. Chan School of Public Health during its Alumni Association Award ceremony on October 14, 2017. A graduate of the Harvard class of 2009, Farouk is the youngest recipient in the award’s history.

With operations in the Philippines, Singapore, Indonesia and Vietnam, mClinica has developed mobile technology to unite pharmacies on a common platform, provide access to new sources of data, and allow for the deployment of data-driven programs that improve patient affordability and health outcomes. Since raising its seed round in 2014, the company has connected thousands of pharmacies across Southeast Asia, providing consolidated access to millions of patients and billions of data points.

In a market dominated by independent pharmacies, rather than chains such as Walgreens, understanding data on patients, health and medicines is challenging. With mClinica, Meralli is changing that, using mobile technology to track medicine and clarify data.

Most recently, mClinica partnered with the Food and Drug Administration of the Philippines to introduce a new mobile app, Electronic Logbook, to digitize prescriptions, making the Philippines the first country in Asia to use a nationwide app to disrupt the pharmacy prescription process.

mClinica was selected into the Endeavor network at the 66th International Selection Panel in Boston, Massachusetts, in September 2016. As mClinica has grown, Farouk has leveraged support from Endeavor Philippines and Endeavor Catalyst, which joined mClinica’s Series A funding round in February 2017.

Read more about mClinica’s receipt of the Public Health Innovator award here.